Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
770 Leser
Artikel bewerten:
(2)

Drug Delivery Devices Market Trends, Dynamics, & Competitive Landscape Report, 2028 | Key Players: Cipla, Roche, 3M, BD, Bayer AG, & Phillips-Medisize: Radiant Insights, Inc.

SAN FRANCISCO, Sept. 25, 2019 /PRNewswire/ -- The global Drug Delivery Devices Market is expected to grow exponentially in the years to come. Drug delivery basically comes across as technologies, approaches, and formulations used for delivering chemicals or drugs in the body. This delivery could be for cure, prevention, or diagnosis of ailments like bacterial and viral diseases, allergies, gastrointestinal diseases, and diabetes. Manufacturing of drug delivery devices involves usage of acrylate hydrogels, polyurethane, ethylene vinyl acetate, silicone, and the other biodegradable substances.

One could also administer drug formulations like antibiotics and insulin through drug delivery devices. These devices could be implantable or conventional. Infusion pumps include insulin infusion pumps, ambulatory infusion pumps, enteral pumps, implantable infusion pumps, and volumetric infusion pumps. Drugs could also be administered through infusion catheters like cannulas, needles, IV sets, and valves. The routes used for administering drugs include paracellular and transcellular routes. By end-users, the drug delivery devices market comprises home care providers, long-term care facilities, and hospitals.

By geography, the drug delivery devices market constitutes North America, Asia Pacific, Europe, LATAM, and MEA. At present, North America leads the market. Europe comes second. These leads could be credited to increasing accessibility, and feasibility of drug delivery services. The number of chronic diseases in these regions is also on the rise. Geriatric population is also increasing at an alarming rate. Asia Pacific is expected to grow at the fastest pace due to extra attention being paid to healthcare; especially by emerging economies like India.

On the other hand, stringent regulatory needs to approve drug delivery devices along with dearth of trained and skilled professionals act as restraints to the market. Dosage error is another restraint.

Download PDF to know more details about "Global Drug Delivery Devices Market" Report 2028.

Innovations in the form of innovation pens are expected to create novel opportunities for novel players in the market. The players contributing to the market include 3M Company, CareFusion Corporation, Smith Medical, Baxter International, Inc., F. Hoffmann-La Roche Ltd., Pfizer, Inc., B. Braun Melsungen AG, and Abbott Laboratories.

This report provides detailed historical analysis of global market for Drug Delivery Devices from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Drug Delivery Devices market.

Access 130 page research report with TOC on "Global Drug Delivery Devices Market" available with Radiant Insights, Inc. @: https://www.radiantinsights.com/research/2013-2028-report-on-global-drug-delivery-devices-market

Market Segmentation:

  • Leading players of Drug Delivery Devices including:
    • Cipla
    • Baxter International
    • Nipro Corporation
    • Roche
    • Boehringer Ingelheim
    • Allergan
    • 3M
    • BD
    • Catalent
    • Valeant Pharmaceuticals
    • Bayer AG
    • Chiesi
    • Phillips-Medisize
    • Johnson & Johnson
    • Shandong Weigao
    • Pfizer
    • B.Braun
    • Novartis AG
    • Zhengkang
    • Gerresheimer
    • COVIDIEN Medtronic
    • Schott forma vitrum
    • Alkermes
    • Skyepharma
  • Market split by Type, can be divided into:
    • Injection type
    • Mucosal type
    • Implanted type
    • Others type
  • Market split by Application, can be divided into:
    • Pharmaceutical companies
    • Hospitals
    • Clinics
    • Other
  • Market split by Sales Channel, can be divided into:
    • Direct Channel
    • Distribution Channel
  • Market segment by Region/Country including:
    • North America (United States, Canada and Mexico)
    • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    • South America Brazil, Argentina, Colombia and Chile etc.)
    • Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

Browse reports of similar category available with Radiant Insights, Inc.:

  • Atherectomy Devices Market
  • Auto-Injectors Market
  • Cardiac Care Medical Equipment Market
  • Patient Temperature Management Devices Market

About Radiant Insights, Inc.:

At Radiant Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact:
Michelle Thoras.
Corporate Sales Specialist
Radiant Insights, Inc.
Phone: +1-415-349-0054
Toll Free: 1-888-928-9744
Email: sales@radiantinsights.com
Web: https://www.radiantinsights.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.